Fig. 2: Strategies for increasing diagnostic yield in rare disease.

Strategic advancements and methodological innovations are essential for enhancing diagnostic accuracy and overcoming current bottlenecks. Key priority areas include improved ability to rapidly resolve variants of unknown significance (VUS), identification of novel disease genes, advancing informatic capabilities, and overcoming diagnostic challenges with emerging technologies134,135. Created with Biorender.com.